PRESS RELEASE published on 04/24/2025 at 17:45, 1 year 1 month ago 2024 FULL YEAR RESULTS Affluent Medical reached major new milestones in executing its clinical roadmap Affluent Medical announces major milestones in its 2024 full-year results including transformative agreements, regulatory validations, and clinical advancements, positioning the company for market launch Medical Technology Affluent Medical Clinical Advancements Market Launch 2024 Full-year Results
BRIEF published on 04/15/2025 at 17:50, 1 year 1 month ago Affluent Medical Advances Towards SPHINX Study for Female SUI Treatment Affluent Medical Artus Device SPHINX Study Female Stress Incontinence Minimally Invasive
PRESS RELEASE published on 04/15/2025 at 17:45, 1 year 1 month ago Affluent Medical Announces Progress Toward European Clinical Study of Artificial Sphincter Artus for the Treatment of Urinary Stress Incontinence in Women. Affluent Medical progresses towards European clinical study of Artificial Sphincter Artus for treating Urinary Stress Incontinence in Women. The upcoming SPHINX study will assess device safety and performance Affluent Medical Women European Clinical Study Artificial Sphincter Artus Urinary Stress Incontinence
PRESS RELEASE published on 04/15/2025 at 17:45, 1 year 1 month ago Affluent Medical Announces Progress Toward European Clinical Study of Artificial Sphincter Artus for the Treatment of Urinary Stress Incontinence in Women Affluent Medical progresses towards European clinical study of Artus artificial sphincter for treating urinary stress incontinence in women. Minimally invasive procedure feasibility confirmed Affluent Medical Women Artus European Clinical Study Urinary Stress Incontinence
BRIEF published on 04/11/2025 at 17:45, 1 year 1 month ago Update of Affluent Medical's capital and voting rights Euronext Paris Share Capital Voting Rights AMF Affluent Medical
BRIEF published on 03/11/2025 at 17:50, 1 year 2 months ago Affluent Medical Appoints New Leaders to Advance Medical Innovations Innovation Medical Devices Clinical Trials Affluent Medical Leadership Appointments
BRIEF published on 03/11/2025 at 17:50, 1 year 2 months ago Affluent Medical Bolsters Team with Key Appointments Market Strategy Medical Appointments Structural Heart Urology Advancements Clinical Operations
PRESS RELEASE published on 03/11/2025 at 17:45, 1 year 2 months ago Affluent Medical announces several key appointments for Medical and Clinical affairs. Affluent Medical announces key appointments for Medical and Clinical affairs, including Dr. Howard C. Herrmann and Pr. Nicolas Barry Delongchamps. Federica Azzimonti joins as Director of Clinical Operations. Aiming to accelerate the company's progress towards market access Medical Affairs Affluent Medical Leadership Key Appointments Clinical Affairs
PRESS RELEASE published on 03/11/2025 at 17:45, 1 year 2 months ago Affluent Medical announces several key appointments for Medical and Clinical affairs. Affluent Medical announces key appointments for Medical and Clinical affairs, including Dr. Howard C. Herrmann and Pr. Nicolas Barry Delongchamps as strategic CMOs. Federica Azzimonti appointed as Director of Clinical Operations Medical Technology Affluent Medical Chief Medical Officer Key Appointments Clinical Operations
BRIEF published on 03/06/2025 at 17:50, 1 year 3 months ago Affluent Medical: Status of shares and voting rights as of February 28, 2025 Share Capital Voting Rights Affluent Medical Financial Markets Medical Implants
Published on 06/10/2026 at 00:00, 7 hours 1 minute ago Onco-Innovations Announces Initiation of API Process Development and Intermediate Scale-Up Program for its Proprietary PNKP Inhibitor Technology
Published on 06/09/2026 at 23:00, 8 hours 1 minute ago NXT Energy Solutions Inc. Announces Results of Annual Meeting of Shareholders
Published on 06/09/2026 at 22:30, 8 hours 31 minutes ago Gamma Resources Announces Receipt of $604,500 from Warrant Exercises
Published on 06/09/2026 at 21:45, 9 hours 16 minutes ago Northfield Announces Change of Corporate Name to Juno International Corporation
Published on 06/09/2026 at 15:00, 16 hours 1 minute ago Worksport Ltd. Reports Additional $50,000 CEO Insider Stock Acquisition, Reinforcing Confidence in Long-Term Value Creation
Published on 06/10/2026 at 06:50, 11 minutes ago Leclanché SA announces Temporary Exemption from the Disclosure Obligation in connection with the Publication and the Filing of the 2025 Annual Report
Published on 06/10/2026 at 06:30, 31 minutes ago Centiel enters U.S. data center market through strategic partnership and multi-million Dollar framework agreement
Published on 06/09/2026 at 22:55, 8 hours 5 minutes ago JACOBS STEPS-UP AS 'OFFICIAL SPONSOR OF STAYING AWAKE' AS SCHEDULE REVEALS SUMMER MATCH TIMES WILL PUSH EUROPEAN FOOTBALL FANS TO THE LIMIT
Published on 06/09/2026 at 22:35, 8 hours 26 minutes ago Eurobattery Minerals publishes Annual Report 2025
Published on 06/09/2026 at 19:32, 11 hours 28 minutes ago 2CRSi SA: 2CRSi announces a €110 million sale of Godì Blackwell Ultra servers in Germany
Published on 06/09/2026 at 19:30, 11 hours 31 minutes ago MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
Published on 06/09/2026 at 18:14, 12 hours 47 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/05/2026
Published on 06/09/2026 at 15:17, 15 hours 43 minutes ago Statement of transactions in own shares from June 1, 2026 to June 5, 2026
Published on 06/09/2026 at 10:37, 20 hours 24 minutes ago Guillemot Corporation S.A. | Weekly report share buyback from June 1 to June 5 2026
Published on 06/09/2026 at 07:00, 1 day ago New strategic Milestone for Biophytis: Official Establishment of Its Joint Venture in Asia